Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups

被引：4

作者：

Gagez, A-L ^{[1
]}

Tuaillon, E. ^{[2
,3
]}

Cezar, R. ^{[3
]}

Dartigeas, C. ^{[4
]}

Mahe, B. ^{[5
]}

Letestu, R. ^{[6
]}

Maisonneuve, H. ^{[7
]}

Gouilleux-Gruart, V. ^{[8
]}

Bollore, K. ^{[2
]}

Ferrant, E. ^{[9
]}

Aurran, T. ^{[10
]}

Feugier, P. ^{[11
]}

Lepretre, S. ^{[12
]}

Cartron, G. ^{[1
,13
]}

机构：

[1] Univ Montpellier, CNRS, UMR 5235, F-34059 Montpellier, France

[2] Univ Montpellier, INSERM, U1058, F-34059 Montpellier, France

[3] CHRU Montpellier, Dept Bacteriol Virol, Montpellier, France

[4] CHRU Tours, Dept Hematol Clin, Tours, France

[5] CHRU Nantes, Dept Hematol Clin, Nantes, France

[6] Hop Avicenne, APHP, GHUPSSD, Serv Hematol Biol, F-93009 Bobigny, France

[7] CHD La Roche Sur Yon, Serv Med Oncohematol, La Roche Sur Yon, France

[8] Univ Tours, CHRU Tours, CNRS, UMR 7292, F-37041 Tours, France

[9] CHRU Dijon, Dept Hematol Clin, Dijon, France

[10] Ctr Paoli Calmette, Marseille, France

[11] CHRU Nancy, Dept Hematol Clin, Nancy, France

[12] Ctr Henri Becquerel, Rouen, France

[13] CHRU Montpellier, Dept Hematol Clin, Montpellier, France

来源：

BLOOD CANCER JOURNAL | 2016年 / 6卷

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; SUBSET; MICE;

D O I：

10.1038/bcj.2015.115

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：e389 / e389

页数：3

共 10 条

[1] Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].

Cartron, G ;

Dacheux, L ;

Salles, G ;

Solal-Celigny, P ;

Bardos, P ;

Colombat, P ;

Watier, H .

BLOOD, 2002, 99 (03) :754-758

[2] Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies [J].

Cartron, Guillaume ;

Trappe, Ralf Ulrich ;

Solal-Celigny, Philippe ;

Hallek, Michael .

CLINICAL CANCER RESEARCH, 2011, 17 (01) :19-30

[3] Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function [J].

DiLillo, DJ ;

Weinberg, J. B. ;

Yoshizaki, A. ;

Horikawa, M. ;

Bryant, J. M. ;

Iwata, Y. ;

Matsushita, T. ;

Matta, K. M. ;

Chen, Y. ;

Venturi, G. M. ;

Russo, G. ;

Gockerman, J. P. ;

Moore, J. O. ;

Diehl, L. F. ;

Volkheimer, A. D. ;

Friedman, D. R. ;

Lanasa, M. C. ;

Hall, R. P. ;

Tedder, T. F. .

LEUKEMIA, 2013, 27 (01) :170-182

[4] Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions [J].

Goede, Valentin ;

Fischer, Kirsten ;

Busch, Raymonde ;

Engelke, Anja ;

Eichhorst, Barbara ;

Wendtner, Clemens M. ;

Chagorova, Tatiana ;

de la Serna, Javier ;

Dilhuydy, Marie-Sarah ;

Illmer, Thomas ;

Opat, Stephen ;

Owen, Carolyn J. ;

Samoylova, Olga ;

Kreuzer, Karl-Anton ;

Stilgenbauer, Stephan ;

Doehner, Hartmut ;

Langerak, Anton W. ;

Ritgen, Matthias ;

Kneba, Michael ;

Asikanius, Elina ;

Humphrey, Kathryn ;

Wenger, Michael ;

Hallek, Michael .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (12) :1101-1110

[5] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[6] Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice [J].

Horikawa, Mayuka ;

Minard-Colin, Veronique ;

Matsushita, Takashi ;

Tedder, Thomas F. .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (11) :4268-4280

[7] Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells [J].

Iwata, Yohei ;

Matsushita, Takashi ;

Horikawa, Mayuka ;

DiLillo, David J. ;

Yanaba, Koichi ;

Venturi, Guglielmo M. ;

Szabolcs, Paul M. ;

Bernstein, Steven H. ;

Magro, Cynthia M. ;

Williams, Armistead D. ;

Hall, Russell P. ;

St Clair, E. William ;

Tedder, Thomas F. .

BLOOD, 2011, 117 (02) :530-541

[8]

Lepretre S, 2014, 56 ASH ANN M SAN FRA, P3329

[9] Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression [J].

Matsushita, Takashi ;

Yanaba, Koichi ;

Bouaziz, Jean-David ;

Fujimoto, Manabu ;

Tedder, Thomas F. .

JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (10) :3420-3430

[10] A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses [J].

Yanaba, Koichi ;

Bouaziz, Jean-David ;

Haas, Karen M. ;

Poe, Jonathan C. ;

Fujimoto, Manabu ;

Tedder, Thomas F. .

IMMUNITY, 2008, 28 (05) :639-650

← 1 →